Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis
Author
Abstract
Suggested Citation
DOI: 10.1038/s41467-022-33944-z
Download full text from publisher
References listed on IDEAS
- Niccolò Bolli & Francesco Maura & Stephane Minvielle & Dominik Gloznik & Raphael Szalat & Anthony Fullam & Inigo Martincorena & Kevin J. Dawson & Mehmet Kemal Samur & Jorge Zamora & Patrick Tarpey & H, 2018. "Genomic patterns of progression in smoldering multiple myeloma," Nature Communications, Nature, vol. 9(1), pages 1-10, December.
- Thomas Nerreter & Sebastian Letschert & Ralph Götz & Sören Doose & Sophia Danhof & Hermann Einsele & Markus Sauer & Michael Hudecek, 2019. "Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T," Nature Communications, Nature, vol. 10(1), pages 1-11, December.
- Bénedith Oben & Guy Froyen & Kylee H. Maclachlan & Daniel Leongamornlert & Federico Abascal & Binbin Zheng-Lin & Venkata Yellapantula & Andriy Derkach & Ellen Geerdens & Benjamin T. Diamond & Ingrid A, 2021. "Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Aleksandrina Goeva & Michael-John Dolan & Judy Luu & Eric Garcia & Rebecca Boiarsky & Rajat M. Gupta & Evan Macosko, 2024. "HiDDEN: a machine learning method for detection of disease-relevant populations in case-control single-cell transcriptomics data," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
- Travis S. Johnson & Parvathi Sudha & Enze Liu & Nathan Becker & Sylvia Robertson & Patrick Blaney & Gareth Morgan & Vivek S. Chopra & Cedric Santos & Michael Nixon & Kun Huang & Attaya Suvannasankha &, 2024. "1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Danielle C. Croucher & Laura M. Richards & Serges P. Tsofack & Daniel Waller & Zhihua Li & Ellen Nong Wei & Xian Fang Huang & Marta Chesi & P. Leif Bergsagel & Michael Sebag & Trevor J. Pugh & Suzanne, 2021. "Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression," Nature Communications, Nature, vol. 12(1), pages 1-14, December.
- Jonathan Schubert & Andrea Schulze & Chrisostomos Prodromou & Hannes Neuweiler, 2021. "Two-colour single-molecule photoinduced electron transfer fluorescence imaging microscopy of chaperone dynamics," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
- Leo Rasche & Carolina Schinke & Francesco Maura & Michael A. Bauer & Cody Ashby & Shayu Deshpande & Alexandra M. Poos & Maurizio Zangari & Sharmilan Thanendrarajan & Faith E. Davies & Brian A. Walker , 2022. "The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
- Markus Haake & Beatrice Haack & Tina Schäfer & Patrick N. Harter & Greta Mattavelli & Patrick Eiring & Neha Vashist & Florian Wedekink & Sabrina Genssler & Birgitt Fischer & Julia Dahlhoff & Fatemeh M, 2023. "Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
- Ming Shi & Jiaojiao Wang & Hongming Huang & Dan Liu & Hai Cheng & Xu Wang & Wei Chen & Zhiling Yan & Wei Sang & Kunming Qi & Depeng Li & Feng Zhu & Zhenyu Li & Jianlin Qiao & Qingyun Wu & Lingyu Zeng , 2024. "Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
- Nina E. Weisser & Mario Sanches & Eric Escobar-Cabrera & Jason O’Toole & Elizabeth Whalen & Peter W. Y. Chan & Grant Wickman & Libin Abraham & Kate Choi & Bryant Harbourne & Antonios Samiotakis & Andr, 2023. "An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33944-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.